Home > Healthcare > Medical Devices > Diagnostic Devices > tonometers market
Get a free sample of Tonometers Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Tonometers Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Key players in the tonometer market, such as Topcon Corporation, NIDEK Co., Ltd., and Canon Inc., focus on technological advancements to cater to growing demand. They are increasingly investing in automated, non-contact, and portable tonometers, integrating AI-driven diagnostics for improved precision and efficiency. These players also emphasize advancements in telemedicine and remote monitoring, addressing the need for homecare and rural healthcare solutions. Furthermore, they focus on expanding their product portfolios to include advanced tonometer models, enhancing accessibility, and ensuring compatibility with the latest ophthalmic technologies in hospitals and clinics worldwide.
Prominent players operating in the tonometers industry include:
Key players in the industry include Canon, HAAG-STREIT GROUP, Huvitz, iCare, Keeler, Kowa, NIDEK, OCULUS, Reichert AMETEK, and Rexxam.
The U.S. tonometers industry was valued at USD 115.8 million in 2024 and is anticipated to grow at a 3% CAGR from 2025 to 2034, driven by the adoption of automated, non-contact, and AI-enabled tonometers.
The applanation tonometer segment accounted for the majority revenue share in 2024 and is expected to exceed USD 369 million by 2034 due to its precision, reliability, and established use in diagnosing and monitoring glaucoma.
The global tonometers industry was valued at USD 373.5 million in 2024 and is projected to grow at a 5.1% CAGR from 2025 to 2034, driven by the rising prevalence of glaucoma and ocular diseases.